Targeting PTBP1 as a therapeutic strategy to reverse lineage-specific splicing of ANXA7 and ensuing EGFR activation in glioblastoma.

Abstract

2075 Background: Tissue-specific splicing involves evolutionarily conserved, alternative exons many of which have functional features that influence cell signalling. The membrane-binding tumor supp...